Cellectis S.A. (CLLS)
NASDAQ·Healthcare·Biotechnology
$3.96
-1.25%
Mkt Cap $361.10M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $13.39M | $12.20M | -8.87% | -$0.20 | -$0.26 | -27.87% | — | — |
| Q4 2025 Nov 7, 2025 | $10.27M | $35.17M | +242.39% | -$0.10 | $0.01 | +110.00% | — | — |
| Q3 2025 Aug 4, 2025 | $8.22M | $16.94M | +106.00% | -$0.10 | -$0.24 | -140.00% | — | — |
| Q2 2025 May 12, 2025 | $12.71M | $10.65M | -16.18% | -$0.19 | -$0.18 | +5.26% | — | — |
| Q1 2025 Mar 13, 2025 | $9.17M | $12.72M | +38.68% | $0.06 | -$0.16 | -366.67% | — | — |
| Q4 2024 Nov 4, 2024 | $20.42M | $16.20M | -20.65% | -$0.20 | -$0.23 | -15.00% | — | — |
| Q3 2024 Aug 6, 2024 | $3.47M | $8.06M | +132.31% | -$0.33 | -$0.28 | +15.15% | — | — |
| Q2 2024 Apr 29, 2024 | $3.47M | $4.53M | +30.49% | -$0.33 | -$0.64 | -93.94% | — | — |
| Q1 2024 Mar 13, 2024 | $1.75M | $283.00K | -83.81% | -$0.22 | -$0.70 | -218.18% | — | — |
| Q4 2023 Nov 6, 2023 | $3.38M | $155.00K | -95.42% | -$0.36 | -$0.31 | +13.89% | — | — |
| Q3 2023 Aug 3, 2023 | $4.48M | $178.00K | -96.02% | -$0.38 | -$0.14 | +63.16% | — | — |
| Q2 2023 May 4, 2023 | $5.99M | $139.00K | -97.68% | -$0.30 | -$0.58 | -93.33% | — | — |
| Q1 2023 Mar 8, 2023 | $18.58M | $16.02M | -13.76% | -$0.75 | -$0.57 | +24.00% | — | — |
| Q4 2022 Nov 3, 2022 | $16.88M | $217.00K | -98.71% | -$0.58 | -$0.63 | -8.62% | — | — |
| Q3 2022 Aug 4, 2022 | $23.46M | $1.35M | -94.25% | -$0.73 | -$0.42 | +42.47% | — | — |
| Q2 2022 May 12, 2022 | $18.60M | $1.70M | -90.88% | -$0.62 | -$0.70 | -12.90% | — | — |
| Q1 2022 Mar 3, 2022 | $9.86M | $13.65M | +38.44% | -$1.05 | -$0.55 | +47.62% | — | — |
| Q4 2021 Nov 4, 2021 | $11.43M | $8.31M | -27.28% | -$0.82 | -$0.82 | +0.00% | — | — |
| Q3 2021 Aug 5, 2021 | $14.62M | $11.18M | -23.53% | -$0.75 | -$0.88 | -17.33% | — | — |
| Q2 2021 May 6, 2021 | — | $25.60M | — | -$0.82 | -$0.28 | +65.85% | — | — |